Trial Profile
Phase III study to compare S-1 as adjuvant therapy after surgery with surgery alone in patients with biliary tract cancer
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 18 Feb 2013
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Biliary cancer
- Focus Therapeutic Use
- 18 Feb 2013 New trial record